Signaling Pathway
Veltuzumab (IMMU-106) is a humanized monoclonal antibody targeting CD20, demonstrating a potent efficacy with an EC50 value ranging between 0.08-0.09 ??g/mL in the Daudi cell line. This antibody is primarily utilized in oncological research, particularly focusing on non-Hodgkin lymphoma (NHL) and other related cancer studies.
重要通知：仅供研究使用。我们不向患者销售。
| Discription | Veltuzumab (IMMU-106) is a humanized monoclonal antibody targeting CD20, demonstrating a potent efficacy with an EC50 value ranging between 0.08-0.09 ??g/mL in the Daudi cell line. This antibody is primarily utilized in oncological research, particularly focusing on non-Hodgkin lymphoma (NHL) and other related cancer studies. |
||
|---|---|---|---|
| Targets |
|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
